Home|Journals|Articles by Year|Audio Abstracts
 

Case Report



5-fluorouracil-induced manic episode in patients with colon cancer: A case report and literature review

Gulcin Elboga, Perihan Gizem Aksoy, Tulay Kus, Elif Karayagmurlu, Gokmen Aktas, Sengul Sahin, Abdurrahman Altindag.




Abstract
Cited by 0 Articles

The combination of 5-fluorouracil (5-FU), irinotecan and bevacizumab (FOLFIRI-beva) is one of the main treatment options for metastatic colon cancer. We present a rare case of irritable mood elevation during FOLFIRI-beva treatment in a man without psychiatric history. A 41-year-old man with colon cancer developed a manic episode after four cycles of chemotherapy. After excluding the other causes, the patient was diagnosed with Medication-induced Bipolar disorder manic episode with mixed features according to the criteria of Diagnostic and Statistical Manual of Mental Disorders, fifth edition. Chemotherapy was discontinued, and antipsychotic treatment with haloperidol and biperidone was started. He recovered after 12 days. While adjustment disorders, depression and delirium are more common in cancer patients, mood disorders are rare during chemotherapy. Neuropsychiatric manifestations are uncommon during 5-FU treatment. Clinicians should keep in mind that a neuropsychological condition or mood disorders may be encountered during chemotherapy especially with 5-FU.

Key words: 5-Fluorouracil; Manic Episode; Mood Disorder; Colon Cancer.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.